Point72 Hong Kong LTD Halozyme Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $1.89 Million - $2.39 Million	56,675 New	56,675 $2.09 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $132,704 - $171,609	3,553 New	3,553 $156,000
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $44,821 - $57,566	-1,402 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $8,750 - $11,206	275 Added 24.4%	1,402 $56,000
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $24,543 - $29,615	-638 Reduced 36.15%	1,127 $46,000
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $68,552 - $90,562	1,765 New	1,765 $80,000
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $84,195 - $109,639	-2,131 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $55,001 - $92,954	2,131 New	2,131 $91,000
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $130,836 - $150,609	-5,083 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $62,481 - $103,084	3,845 Added 310.58%	5,083 $136,000
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $26,729 - $41,979	-1,923 Reduced 60.84%	1,238 $22,000
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $47,193 - $61,734	3,161 New	3,161 $56,000
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $693 - $970	-52 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $867 - $957	52 New	52 $1,000
Q2 2018 Aug 14, 2018	SELL	$16.87 - $20.3 $522 - $629	-31 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.06 - $21.2 $528 - $657	31 New	31 $1,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.